Cymbalta, the drug manufactured by Eli Lilly is now legally approved to be marketed in Europe.
The drug is used as treatment for generalized anxiety disorder where the victim experiences a great deal of worry and anxiety. Anxiety disorder is known to afflict 9 million people in Europe.
The drug had earlier been approved for use to alleviate severe depressive disorder and neuropathic pain.
For instance, in the United States, the drug was used to treat anxiety diabetic nerve pain, major depressive disorder and fibromyalgia.
Sales for this drug had touched $2.1 billion in 2007. Shares of Eli Lilly has shown progress, up by 1.7%.